These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 8052431)

  • 21. Long-term efficacy of low-density lipoprotein apheresis for focal and segmental glomerulosclerosis.
    Kawasaki Y; Suzuki S; Matsumoto A; Takano K; Suyama K; Hashimoto K; Suzuki J; Suzuki H; Hosoya M
    Pediatr Nephrol; 2007 Jun; 22(6):889-92. PubMed ID: 17277952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interleukin-18 expression in peripheral blood mononuclear cells in children with steroid-resistant nephrotic syndrome].
    Jiang HK; Luo G; Jiang H
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):337-40. PubMed ID: 19470251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pravastatin administration to hyperlipidemia in patients with nephrotic syndrome.
    Shibasaki T; Nakano H; Matsuda H; Ohno I; Matsumoto H; Misawa T; Ishimoto F; Sakai O
    Nihon Jinzo Gakkai Shi; 1993 Nov; 35(11):1243-8. PubMed ID: 8139136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of renal insufficiency after long-standing steroid-responsive nephrotic syndrome.
    Trainin EB; Gomez-Leon G
    Int J Pediatr Nephrol; 1982 Jun; 3(2):55-8. PubMed ID: 7107119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
    Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significantly rapid relief from steroid-resistant nephrotic syndrome by LDL apheresis compared with steroid monotherapy.
    Muso E; Mune M; Fujii Y; Imai E; Ueda N; Hatta K; Imada A; Takemura T; Miki S; Kuwahara T; Takamitsu Y; Tsubakihara Y;
    Nephron; 2001 Dec; 89(4):408-15. PubMed ID: 11721158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pattern of steroid resistant nephrotic syndrome in children living in the kingdom of Saudi Arabia: a single center study.
    Kari JA; Halawani M; Mokhtar G; Jalalah SM; Anshasi W
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):854-7. PubMed ID: 19736491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation.
    Zimmerman SW
    Clin Nephrol; 1984 Jul; 22(1):32-8. PubMed ID: 6383672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic advances in glomerular nephropathies].
    Pérez García R
    Rev Clin Esp; 1991 Nov; 189(7):305-8. PubMed ID: 1767085
    [No Abstract]   [Full Text] [Related]  

  • 30. Nephrotic syndrome in African children: lack of evidence for 'tropical nephrotic syndrome'?
    Doe JY; Funk M; Mengel M; Doehring E; Ehrich JH
    Nephrol Dial Transplant; 2006 Mar; 21(3):672-6. PubMed ID: 16326742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic apheresis in idiopathic nephrotic syndrome].
    Moriconi L
    G Ital Nefrol; 2012; 29 Suppl 54():S67-72. PubMed ID: 22388834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome.
    Bazzi C; Petrini C; Rizza V; Arrigo G; D'Amico G
    Kidney Int; 2000 Oct; 58(4):1732-41. PubMed ID: 11012907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [LDL-apheresis for refractory nephrotic syndrome].
    Muso E
    Nihon Jinzo Gakkai Shi; 2010; 52(7):928-33. PubMed ID: 21077343
    [No Abstract]   [Full Text] [Related]  

  • 34. Depression of normal lymphocyte transformation by sera of patients with minimal change nephropathy and other forms of nephrotic syndrome.
    Taube D; Chapman S; Brown Z; Williams DG
    Clin Nephrol; 1981 Jun; 15(6):286-90. PubMed ID: 7249426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apheresis technologies for prevention and regression of atherosclerosis: clinical results.
    Bambauer R; Schneidewind JM; Latza R
    ASAIO J; 1999; 45(5):403-7. PubMed ID: 10503615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of angiotensin converting enzyme inhibitor and calcium channel blocker in the treatment of steroid-resistant idiopathic nephrotic syndrome.
    Kumar NS; Singh AK; Mishra RN; Prakash J
    J Assoc Physicians India; 2004 Jun; 52():454-8. PubMed ID: 15645954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathological diagnosis and outcome of paediatric nephrotic syndrome.
    Ejaz I; Khan HI; Javaid BK; Rasool G; Bhatti MT
    J Coll Physicians Surg Pak; 2004 Apr; 14(4):229-33. PubMed ID: 15228828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adult minimal-change disease: clinical characteristics, treatment, and outcomes.
    Waldman M; Crew RJ; Valeri A; Busch J; Stokes B; Markowitz G; D'Agati V; Appel G
    Clin J Am Soc Nephrol; 2007 May; 2(3):445-53. PubMed ID: 17699450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of steroid-resistant nephrotic syndrome with cyclosporine: study of 17 cases and a literature review.
    Frassinetti Castelo Branco Camurça Fernandes P; Bezerra Da Silva G; De Sousa Barros FA; Costa Oliveira CM; Kubrusly M; Evangelista JB
    J Nephrol; 2005; 18(6):711-20. PubMed ID: 16358229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary glomerulonephritides with nephrotic syndrome. Limitations of therapy in adult patients.
    Schena FP
    J Nephrol; 1999; 12 Suppl 2():S125-30. PubMed ID: 10688412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.